Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31598456 | 0.80 | — | — | |
| SCHEMBL7799639 | 0.80 | TSHR (0.37) | TSHRMAPK1HSD17B10TDP1THRB | |
| SCHEMBL28621880 | 0.80 | TSHR (0.41) | TSHRMAPK1HSD17B10TDP1THRB | |
| SCHEMBL9161010 | 0.78 | TSHR (0.40) | TSHRMAPK1HSD17B10TDP1THRB | |
| SCHEMBL8837708 | 0.78 | TSHR (0.36) | TSHRMAPK1HSD17B10TDP1THRB | |
| Methylamine SCHEMBL28188491 | 0.78 | TSHR (0.37) | TSHRMAPK1HSD17B10TDP1THRB | |
| SCHEMBL29232749 | 0.77 | TSHR (0.35) | TSHRMAPK1HSD17B10TDP1THRB | |
| SCHEMBL3630326 | 0.77 | TSHR (0.39) | TSHRMAPK1HSD17B10TDP1THRB | |
| SCHEMBL27420794 | 0.77 | TSHR (0.35) | TSHRMAPK1HSD17B10TDP1THRB | |
| SCHEMBL1982478 | 0.77 | TSHR (0.39) | TSHRMAPK1HSD17B10TDP1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240158667-A1 | POLISHING SLURRY COMPOSITION | KCTECH CO., LTD. (KR) | 2024-05-16 | — | — | US | claimed |
| CN-117924202-A | Chrome-free tanning agent containing carboxylic acid sulfonate structure and preparation method thereof | 浙江康诺和新材料有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-116848205-A | Polishing slurry composition | 凯斯科技股份有限公司 | 2023-10-03 | — | — | CN | claimed |
| WO-2022231115-A1 | POLISHING SLURRY COMPOSITION | 주식회사 케이씨텍 | 2022-11-03 | — | — | WO | claimed |
| US-20150099709-A1 | GHRELIN RECEPTOR AGONISTS FOR THE TREATMENT OF ACHLORHYDRIA | RAQUALIA PHARMA INC. (JP) | 2015-04-09 | — | — | US | claimed |
| EP-2854810-A1 | GHRELIN RECEPTOR AGONISTS FOR THE TREATMENT OF ACHLORHYDRIA | RaQualia Pharma Inc (JP) | 2015-04-08 | — | — | EP | claimed |
| WO-2013175805-A1 | GHRELIN RECEPTOR AGONISTS FOR THE TREATMENT OF ACHLORHYDRIA | RAQUALIA PHARMA INC. (JP) | 2013-11-28 | — | — | WO | claimed |
| US-20020160961-A1 | Compositions for the treatment of the catabolic state of prolonged critical illness | NOVO NORDISK A/S (DK) | 2002-10-31 | — | — | US | claimed |
| EP-1200111-A1 | COMPOSITIONS FOR THE TREATMENT OF THE CATABOLIC STATE OF PROLONGED CRITICAL ILLNESS | NOVO NORDISK A/S (DK) | 2002-05-02 | — | — | EP | claimed |
| WO-2000074702-A1 | COMPOSITIONS FOR THE TREATMENT OF THE CATABOLIC STATE OF PROLONGED CRITICAL ILLNESS | NOVO NORDISK A/S (DK) | 2000-12-14 | — | — | WO | claimed |
| EP-0736039-B1 | COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK AS (DK) | 2000-10-25 | — | — | EP | claimed |
| US-5990084-A | A SERIES OF TRUNCATED ANALOGS OF HGHRH (HUMAN GROWTH HORMONE RELEASING HORMONE); ANALOG ACTIVATES THE GHRH RECEPTOR, BUT HAS IMPROVED METABOLIC STABILITY, DECREASED IMMUNOGENICITY AND LOWER COST OF PRODUCTION | NOVO NORDISK A/S (DK) | 1999-11-23 | — | — | US | claimed |
| WO-1999031124-A1 | CHOLIC ACID-BASED SCAFFOLDS FOR MULTIDIMENSIONAL MOLECULAR PRESENTATION OF PEPTIDES | NOVO NORDISK A/S (DK) | 1999-06-24 | — | — | WO | claimed |
| EP-0910579-A1 | COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK A/S (DK) | 1999-04-28 | — | — | EP | claimed |
| US-5767085-A | PEPTIDE DERIVATIVES | NOVO NORDISK A/S (DK) | 1998-06-16 | — | — | US | claimed |
| WO-1997040071-A1 | COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK A/S (DK) | 1997-10-30 | — | — | WO | claimed |
| EP-0736039-A1 | COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK A/S (DK) | 1996-10-09 | — | — | EP | claimed |
| WO-1995017423-A1 | COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK A/S (DK) | 1995-06-29 | — | — | WO | claimed |
| US-12528974-B2 | Polishing slurry composition | KCTECH CO., LTD. (KR) | 2026-01-20 | — | — | US | disclosed |
| WO-1997040071-A1 | COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK A/S (DK) | 1997-10-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150099709-A1 | GHRELIN RECEPTOR AGONISTS FOR THE TREATMENT OF ACHLORHYDRIA | GIPR, GHSR, GLP1R | TSHR 140/4885MAPK1 1802/4885HSD17B10 1137/4885 |
| US-12528974-B2 | Polishing slurry composition | ACP1, CA1, CA11 | TSHR 4253/4885MAPK1 727/4885HSD17B10 4144/4885 |
| US-20020160961-A1 | Compositions for the treatment of the catabolic state of prolonged critical illness | CRH, CRHBP, TRHDE | TSHR 77/4885MAPK1 4038/4885HSD17B10 1392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.